Romosozumab and Denosumab Combination Therapy for Osteoporosis
Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
In this research study, the investigators want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.